Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 12Recruiting 11Completed 6Active not recruiting 3Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 2Gynecologic 2Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2

Interventions

Cisplatin 28toripalimab 14Radiotherapy 12Gemcitabine 12Capecitabine 11Radiotherapy, Intensity-Modulated 10pembrolizumab 9Surgical Procedures, Operative 9Docetaxel 9tislelizumab 8Carboplatin 7Drug Therapy 6Blood Specimen Collection 6anlotinib 5Taxes 5Paclitaxel 5Nivolumab 5Fluorouracil 5Cetuximab 5130-nm albumin-bound paclitaxel 5Thyroxine 4Magnetic Resonance Spectroscopy 4Cyclophosphamide 4trametinib 3sintilimab 3camrelizumab 3Radiation 3Observation 3Injections 3Immune Checkpoint Inhibitors 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × nimotuzumab × Head & Neck × Clear all
NCT07535567 2026-04-30

NimoBenSeq

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2/3 Not yet recruiting
386 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07354984 2026-01-21

PIONEER-HN

Sun Yat-sen University

Phase 2 Not yet recruiting
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡